Beta-adrenolityki (Q323809): Difference between revisions

@@ aliases / en / 0 / aliases / en / 0 @@
+Beta-blokery
@@ aliases / en / 1 / aliases / en / 1 @@
+Leki beta-adrenolityczne
@@ aliases / en / 2 / aliases / en / 2 @@
+Leki blokujące receptory beta-adrenergiczne
@@ aliases / pl / 0 / aliases / pl / 0 @@
+Beta-blokery
@@ aliases / pl / 1 / aliases / pl / 1 @@
+Leki beta-adrenolityczne
@@ aliases / pl / 2 / aliases / pl / 2 @@
+Leki blokujące receptory beta-adrenergiczne
@@ Property / National Library Identifier @@
+a0000001023181
@@ Property / National Library Identifier: a0000001023181 / rank @@
+Normal rank
@@ Property / Related Subject @@
+Leki hipotensyjne
@@ Property / Related Subject: Leki hipotensyjne / rank @@
+Normal rank
@@ Property / Related Subject @@
+Leki przeciwdławicowe
@@ Property / Related Subject: Leki przeciwdławicowe / rank @@
+Normal rank
@@ Property / Related Subject @@
+Receptory adrenergiczne
@@ Property / Related Subject: Receptory adrenergiczne / rank @@
+Normal rank
@@ Property / Related Subject @@
+Betaksolol
@@ Property / Related Subject: Betaksolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Bisoprolol
@@ Property / Related Subject: Bisoprolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Esmolol
@@ Property / Related Subject: Esmolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Metoprolol
@@ Property / Related Subject: Metoprolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Nebiwolol
@@ Property / Related Subject: Nebiwolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Propranolol
@@ Property / Related Subject: Propranolol / rank @@
+Normal rank
@@ Property / Related Subject @@
+Talinolol
@@ Property / Related Subject: Talinolol / rank @@
+Normal rank
@@ Property / Type @@
+Unknown
@@ Property / Type: Unknown / rank @@
+Normal rank
@@ Property / Version @@
+P51136T84184
@@ Property / Version: P51136T84184 / rank @@
+Normal rank

Beta-adrenolityki (Q323809): Difference between revisions

Latest revision as of 09:36, 27 November 2023

Statements

Navigation menu

Search